Radcliffe Capital Management
DRTSW icon

Radcliffe Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Radcliffe Capital Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60,700
Closed -$354K – 886
2022
Q3 		$354K Sell
60,700
-44,300
-42% -$26.1K 0.01% 1102
2022
Q2 		$946K Buy
+105,000
New +$58.5K 0.02% 1008

Other funds holding DRTSW

LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Angelo Gordon & Co
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
Corbin Capital Partners
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Chicago Partners Investment Group
Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return
HGC Investment Management
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Moore Capital Management
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Radcliffe Capital Management's DRTSW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2022, closing a stake of 60,700 shares — an estimated $354K sold.

Radcliffe Capital Management first reported a position in DRTSW in Q2 2022 and held it in 2 quarters. The position peaked at $946K in Q2 2022. 34 funds tracked by Wall St. Rank hold DRTSW as of Q4 2022.

  • Radcliffe Capital Management reported no remaining Alpha Tau Medical Warrant position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 60,700 Alpha Tau Medical Warrant shares in Q4 2022, an estimated $354K.
  • Radcliffe Capital Management first reported a position in Alpha Tau Medical Warrant in Q2 2022 and held it in 2 quarters.
  • Radcliffe Capital Management's Alpha Tau Medical Warrant position peaked at $946K in Q2 2022.
  • 34 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.